Taiwan FDA registration f7ed143ec83afe636cc83bb8a8c6f580
“NanoString” nCounter Dx Analysis System
TW: “納斯凌”微量多基因分析儀
Taiwan·Risk Class 2·MD·NanoString Technologies, Inc·Registered Dec 05, 2018 – Dec 05, 2028ActiveRegistration details
- Analysis ID
- f7ed143ec83afe636cc83bb8a8c6f580
- License Form
- Ministry of Health Medical Device Import No. 031951
- Customs Code
- DHA05603195103
Company information
- Manufacturer
- NanoString Technologies, Inc
- Manufacturer Country
- United States
- Authorized Representative
- COLD SPRING BIOTECH CORP.
Product details
- Intended Use
- This product is a clinical multi-standard detection system instrument, which is composed of a preparation workstation and a digital analyzer. The preparation workstation is a liquid handler that automates post-hybridization processing. A digital analyzer is a fluorescence microscope that measures and classifies multiple signals (generated by reporter probes bound to mRNA) from clinical FFPE specimens.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A2570 Clinical Multi-standard Detection System Instrument
- Import Information
- Imported from abroad
Dates and status
- Registration Date
- Dec 05, 2018
- Expiry Date
- Dec 05, 2028
About this record
Access comprehensive regulatory information for “NanoString” nCounter Dx Analysis System in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number f7ed143ec83afe636cc83bb8a8c6f580 and manufactured by NanoString Technologies, Inc. The authorized representative in Taiwan is COLD SPRING BIOTECH CORP..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices